Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 2,340 NXTC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | NextCure, Inc. (NXTC) | Grant/Award | 2,340 | n/a |
| Mar 3, 2026 | ARVINAS, INC. (ARVN) | Sale | 4,688 | $62.1K |
| Jun 24, 2025 | NextCure, Inc. (NXTC) | Grant/Award | 18,700 | n/a |
| Feb 25, 2025 | ARVINAS, INC. (ARVN) | Sale | 26,184 | $438.6K |
| Feb 19, 2025 | ARVINAS, INC. (ARVN) | Grant/Award | 152,000 | n/a |
| Jun 21, 2024 | NextCure, Inc. (NXTC) | Grant/Award | 18,700 | n/a |
| Feb 27, 2024 | ARVINAS, INC. (ARVN) | Grant/Award | 124,450 | n/a |
| Jun 23, 2023 | NextCure, Inc. (NXTC) | Grant/Award | 14,250 | n/a |
| Mar 3, 2023 | ARVINAS, INC. (ARVN) | Exercise/Conversion | 17,510 | n/a |
| Feb 24, 2023 | ARVINAS, INC. (ARVN) | Grant/Award | 61,975 | n/a |